ReWalk Robotics welcomes Joe Turk to its Board of Directors

– USA, MA –  ReWalk Robotics. Ltd. (NASDAQ: RWLK), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the appointment of Joe Turk to its Board of Directors, effective today.

“As ReWalk is now preparing for implementation of broader commercialization efforts based on an anticipated expanded coverage position in Germany and the United States, we sought to increase direct commercialization skills and experience within our Board. Joe has a successful track record of development and implementation, and we believe his experience is highly valuable to our goals in developing the company. We are thrilled to welcome him to the Board,” said Board Chairman, Jeff Dykan.

About Joseph Turk, Jr.

After initiating his career at McKinsey and Company, Joe Turk has assembled an extensive history in the medical device industry beginning with his role as Director of New Business Development at Boston Scientific. Subsequently, he held multiple roles at NxStage Medical, including President, where he led all commercialization activities including securing favorable Medicare payment policies; overseeing all commercial functions for the implementation and growth of their key products; and coordinating key M&A efforts for building the company. Currently, he is an EVP at Fresenius Medical Care North America and the President of the Renal Therapies Group. Prior to that he was the President of FMC-NA’s Home and Critical Care Therapies efforts.

“Being able to improve people’s lives through commercializing novel technologies has been a driving force in my career,” said Joe Turk. “Working with a mission-driven company with life-changing technologies such as ReWalk is a natural fit. I look forward to contributing my insight to help ReWalk develop successful broad commercialization strategies that enable better health for the disabled community, all within the context of a sustainable business model.”

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the United States, Israel and Germany.

For more information : https://rewalk.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team